In a challenging environment, Sartorius Stedim Biotech, a leading provider of innovative technologies for the manufacture of ...

Shares in Sartorius jumped 15.6% on Tuesday after the Franco-German lab supplies maker's preliminary annual results beat expectations and despite a cautious outlook for 2025.

Kepler Capital analyst Oliver Reinberg maintained a Hold rating on Sartorius Stedim Biotech (0RG8 – Research Report) on January 28 and set a ...

Sartorius Stedim Biotech SA (SDMHF) reports steady revenue growth and robust order intake, while addressing market pressures and strategic expansions.

Jefferies analyst James Vane maintained a Buy rating on Sartorius Stedim Biotech (0RG8 – Research Report) today and set a price target of ...

Sartorius Stedim Biotech S.A. engages in the production and sale of instruments and consumables for the biopharmaceutical industry worldwide. The company offers various products, such as cell ...

Sartorius Stedim Biotech SA / Key word(s): Annual Results/Quarter Results Sartorius Stedim Biotech publishes preliminary, unaudited results for fiscal 2024 28-Jan-2025 / 07:04 CET/CEST ...

Sartorius Stedim Biotech SA / Key word(s): Annual Results/Quarter Results Sartorius Stedim Biotech publishes preliminary, unaudited results for fiscal 2024 28-Jan-2025 / 07:04 CET/CEST ...